2022 Q1 Form 10-Q Financial Statement

#000095017022007797 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $150.5M $134.0M
YoY Change 12.29% 19.35%
Cost Of Revenue $33.16M $23.30M
YoY Change 42.34% 3.74%
Gross Profit $117.3M $110.7M
YoY Change 5.97% 23.25%
Gross Profit Margin 77.96% 82.61%
Selling, General & Admin $21.06M $16.40M
YoY Change 28.4% -3.51%
% of Gross Profit 17.95% 14.82%
Research & Development $26.55M $23.31M
YoY Change 13.9% 19.51%
% of Gross Profit 22.63% 21.05%
Depreciation & Amortization $5.600M $4.300M
YoY Change 30.23% 18.95%
% of Gross Profit 4.77% 3.88%
Operating Expenses $55.06M $47.14M
YoY Change 16.78% 4.04%
Operating Profit $62.25M $63.56M
YoY Change -2.06% 42.81%
Interest Expense $291.0K $100.0K
YoY Change 191.0% -95.24%
% of Operating Profit 0.47% 0.16%
Other Income/Expense, Net $257.0K $192.0K
YoY Change 33.85% -4.0%
Pretax Income $62.51M $63.75M
YoY Change -1.95% 35.93%
Income Tax $12.50M $12.10M
% Of Pretax Income 20.0% 18.98%
Net Earnings $49.97M $51.69M
YoY Change -3.32% 35.47%
Net Earnings / Revenue 33.21% 38.57%
Basic Earnings Per Share $1.05 $1.09
Diluted Earnings Per Share $1.05 $1.08
COMMON SHARES
Basic Shares Outstanding 47.37M 47.27M
Diluted Shares Outstanding 47.44M 47.33M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $682.5M $727.0M
YoY Change -6.12% 13.63%
Cash & Equivalents $357.4M $726.3M
Short-Term Investments $325.1M $549.7M
Other Short-Term Assets $29.12M $39.60M
YoY Change -26.46% 153.85%
Inventory $143.2M $101.4M
Prepaid Expenses
Receivables $104.9M $91.33M
Other Receivables $0.00 $0.00
Total Short-Term Assets $959.8M $959.3M
YoY Change 0.05% 18.13%
LONG-TERM ASSETS
Property, Plant & Equipment $131.9M $107.8M
YoY Change 22.32% 11.84%
Goodwill $15.54M
YoY Change
Intangibles
YoY Change
Long-Term Investments $164.1M $8.500M
YoY Change 1830.94% 70.0%
Other Assets $126.2M $130.7M
YoY Change -3.43% 18.71%
Total Long-Term Assets $527.4M $351.2M
YoY Change 50.18% 8.29%
TOTAL ASSETS
Total Short-Term Assets $959.8M $959.3M
Total Long-Term Assets $527.4M $351.2M
Total Assets $1.487B $1.311B
YoY Change 13.49% 15.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.06M $14.70M
YoY Change 84.11% 41.35%
Accrued Expenses $26.96M $21.50M
YoY Change 25.4% -6.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $178.3M $166.3M
YoY Change 7.19% 21.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $78.46M $191.7M
YoY Change -59.07% 25.21%
Total Long-Term Liabilities $78.46M $191.7M
YoY Change -59.07% 25.21%
TOTAL LIABILITIES
Total Short-Term Liabilities $178.3M $166.3M
Total Long-Term Liabilities $78.46M $191.7M
Total Liabilities $355.9M $358.0M
YoY Change -0.58% 23.58%
SHAREHOLDERS EQUITY
Retained Earnings $535.9M
YoY Change
Common Stock $491.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $41.28M
YoY Change
Treasury Stock Shares $1.366M
Shareholders Equity $1.131B $952.5M
YoY Change
Total Liabilities & Shareholders Equity $1.487B $1.311B
YoY Change 13.49% 15.32%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $49.97M $51.69M
YoY Change -3.32% 35.47%
Depreciation, Depletion And Amortization $5.600M $4.300M
YoY Change 30.23% 18.95%
Cash From Operating Activities $52.61M $29.50M
YoY Change 78.36% 413.33%
INVESTING ACTIVITIES
Capital Expenditures $10.75M $9.938M
YoY Change 8.18% 107.82%
Acquisitions
YoY Change
Other Investing Activities $25.33M $95.80M
YoY Change -73.56% -5.89%
Cash From Investing Activities $14.56M $85.54M
YoY Change -82.98% -11.83%
FINANCING ACTIVITIES
Cash Dividend Paid $14.25M $9.487M
YoY Change 50.16% 33.66%
Common Stock Issuance & Retirement, Net $403.0K $348.0K
YoY Change 15.8% 34.36%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -21.74M -18.77M
YoY Change 15.8% 61.07%
NET CHANGE
Cash From Operating Activities 52.61M 29.50M
Cash From Investing Activities 14.56M 85.54M
Cash From Financing Activities -21.74M -18.77M
Net Change In Cash 45.43M 96.27M
YoY Change -52.81% 5.65%
FREE CASH FLOW
Cash From Operating Activities $52.61M $29.50M
Capital Expenditures $10.75M $9.938M
Free Cash Flow $41.86M $19.56M
YoY Change 114.01% 1928.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001005284
CY2022Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2022Q1 oled State And Foreign Income Tax Returns Subject To Examination Period Minimum
StateAndForeignIncomeTaxReturnsSubjectToExaminationPeriodMinimum
P3Y
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
1-12031
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL DISPLAY CORPORATION
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-2372688
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Phillips Boulevard
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Ewing
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08618
CY2022Q1 dei City Area Code
CityAreaCode
609
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
671-0980
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
OLED
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47214329
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
357424000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
311993000
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
325055000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
351194000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104947000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
107639000
CY2022Q1 us-gaap Inventory Net
InventoryNet
143240000
CY2021Q4 us-gaap Inventory Net
InventoryNet
134160000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
29120000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
20948000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
959786000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
925934000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
97979000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
92461000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
131879000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
128832000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
178782000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
173635000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44521000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
49668000
CY2022Q1 oled Other Finite Lived Intangible Assets Accumulated Amortization
OtherFiniteLivedIntangibleAssetsAccumulatedAmortization
7918000
CY2021Q4 oled Other Finite Lived Intangible Assets Accumulated Amortization
OtherFiniteLivedIntangibleAssetsAccumulatedAmortization
7565000
CY2022Q1 oled Other Finite Lived Intangible Assets Net
OtherFiniteLivedIntangibleAssetsNet
9370000
CY2021Q4 oled Other Finite Lived Intangible Assets Net
OtherFiniteLivedIntangibleAssetsNet
9711000
CY2022Q1 us-gaap Goodwill
Goodwill
15535000
CY2021Q4 us-gaap Goodwill
Goodwill
15535000
CY2022Q1 us-gaap Long Term Investments
LongTermInvestments
164130000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
168076000
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
35788000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
33453000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
126222000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
135710000
CY2022Q1 us-gaap Assets
Assets
1487231000
CY2021Q4 us-gaap Assets
Assets
1466919000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
27064000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14955000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26960000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45474000
CY2022Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
111778000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
120864000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12452000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6645000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
178254000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
187938000
CY2022Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
31735000
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
36217000
CY2022Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
67481000
CY2021Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
66773000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
78461000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
76077000
CY2022Q1 us-gaap Liabilities
Liabilities
355931000
CY2021Q4 us-gaap Liabilities
Liabilities
367005000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
2000
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
2000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49099830
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49065924
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47734182
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47700276
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
491000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
491000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
658050000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
658728000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
535936000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
500212000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21895000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18235000
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1365648
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1365648
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
41284000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
41284000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1131300000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1099914000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1487231000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1466919000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
150470000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
134000000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33163000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23298000
CY2022Q1 us-gaap Gross Profit
GrossProfit
117307000
CY2021Q1 us-gaap Gross Profit
GrossProfit
110702000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26545000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23305000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21062000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16404000
CY2022Q1 oled Amortization Of Acquired Technology And Other Intangible Assets
AmortizationOfAcquiredTechnologyAndOtherIntangibleAssets
5498000
CY2021Q1 oled Amortization Of Acquired Technology And Other Intangible Assets
AmortizationOfAcquiredTechnologyAndOtherIntangibleAssets
5488000
CY2022Q1 oled Patent Costs
PatentCosts
1798000
CY2021Q1 oled Patent Costs
PatentCosts
1835000
CY2022Q1 us-gaap Royalty Expense
RoyaltyExpense
154000
CY2021Q1 us-gaap Royalty Expense
RoyaltyExpense
112000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
55057000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
47144000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
62250000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
63558000
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
291000
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
133000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-34000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
59000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
257000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
192000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
62507000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
63750000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12537000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12063000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
49970000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
51687000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.09
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.05
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.08
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47369764
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47267921
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47440281
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47329704
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
49970000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
51687000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1097000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
17000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3935000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-58000
CY2022Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
-143000
CY2021Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
-335000
CY2022Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
509000
CY2021Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
1174000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-234000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-106000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3660000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1010000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
46310000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52697000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1099914000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
49970000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3660000
CY2022Q1 us-gaap Dividends Cash
DividendsCash
14246000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5979000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7896000
CY2022Q1 oled Issuance Of Common Stock To Board Of Directors And Scientific Advisory Board Value
IssuanceOfCommonStockToBoardOfDirectorsAndScientificAdvisoryBoardValue
730000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
509000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1131300000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
912714000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
51687000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1010000
CY2021Q1 us-gaap Dividends Cash
DividendsCash
9487000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5116000
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9634000
CY2021Q1 oled Issuance Of Common Stock To Board Of Directors And Scientific Advisory Board Value
IssuanceOfCommonStockToBoardOfDirectorsAndScientificAdvisoryBoardValue
630000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
432000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
952468000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
49970000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
51687000
CY2022Q1 oled Contract With Customer Liability Amortization Of Deferred Revenue And Recognition Of Unbilled Receivables
ContractWithCustomerLiabilityAmortizationOfDeferredRevenueAndRecognitionOfUnbilledReceivables
64106000
CY2021Q1 oled Contract With Customer Liability Amortization Of Deferred Revenue And Recognition Of Unbilled Receivables
ContractWithCustomerLiabilityAmortizationOfDeferredRevenueAndRecognitionOfUnbilledReceivables
57648000
CY2022Q1 us-gaap Depreciation
Depreciation
5627000
CY2021Q1 us-gaap Depreciation
Depreciation
4263000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5498000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5488000
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
84000
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
667000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-271000
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-70000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6085000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5200000
CY2022Q1 oled Stock Based Compensation To Board Of Directors And Scientific Advisory Board
StockBasedCompensationToBoardOfDirectorsAndScientificAdvisoryBoard
430000
CY2021Q1 oled Stock Based Compensation To Board Of Directors And Scientific Advisory Board
StockBasedCompensationToBoardOfDirectorsAndScientificAdvisoryBoard
330000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1380000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
515000
CY2022Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
1359000
CY2021Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
2228000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2692000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9066000
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-5400000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-9488000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
7133000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4261000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14562000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
85544000
CY2022Q1 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
9164000
CY2021Q1 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
10498000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
3525000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-21136000
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
5807000
CY2021Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-666000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
45891000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
53000000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2384000
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
6935000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
52608000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29496000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10751000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9938000
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
298000
CY2022Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
24915000
CY2021Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
4220000
CY2022Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
50240000
CY2021Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
100000000
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
403000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
348000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7896000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9634000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
14246000
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
9487000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21739000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18773000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
45431000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
96267000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
311993000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
630012000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
357424000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
726279000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-5031000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-66000
CY2022Q1 oled Other Significant Non Cash Transaction Increase Decrease In Accounts Payable And Accrued Expenses Related To Purchases Of Property And Equipment
OtherSignificantNonCashTransactionIncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedToPurchasesOfPropertyAndEquipment
2077000
CY2021Q1 oled Other Significant Non Cash Transaction Increase Decrease In Accounts Payable And Accrued Expenses Related To Purchases Of Property And Equipment
OtherSignificantNonCashTransactionIncreaseDecreaseInAccountsPayableAndAccruedExpensesRelatedToPurchasesOfPropertyAndEquipment
-27000
CY2022Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">1. BUSINESS:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Universal Display Corporation and its subsidiaries (the Company) is a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. OLEDs are thin, lightweight and power-efficient solid-state devices that emit light that can be manufactured on both flexible and rigid substrates, making them highly suitable for use in full-color displays and as lighting products. OLED displays are capturing a growing share of the display market, especially in the mobile phone, television, wearable, tablet, notebook and personal computer, augmented reality (AR), virtual reality (VR) and automotive markets. The Company believes this is because OLEDs offer potential advantages over competing display technologies with respect to power efficiency, contrast ratio, viewing angle, video response time, form factor and manufacturing cost. The Company also believes that OLED lighting products have the potential to replace many existing light sources in the future because of their high-power efficiency, excellent color rendering index, low operating temperature and novel form factor. The Company’s technology leadership, intellectual property position, and the Company’s more than 20 years of experience working closely with leading OLED display manufacturers are some of the competitive advantages that should enable the Company to continue to share in the revenues from OLED displays and lighting products as they gain wider acceptance.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company’s primary business strategy is to (1) develop new OLED materials and sell existing and new materials to product manufacturers of products for display applications, such as mobile phones, televisions, wearables, tablets, portable media devices, notebook computers, personal computers and automotive applications, and specialty and general lighting products; and (2) further develop and either license or otherwise commercialize the Company’s proprietary OLED material, device design and manufacturing technologies to those manufacturers. The Company has established a significant portfolio of proprietary OLED technologies and materials, primarily through internal research and development efforts and acquisitions of patents and patent applications, as well as maintaining long-standing, and establishing new relationships with world-class universities, research institutions and strategic manufacturing partnerships. The Company currently owns, exclusively licenses or has the sole right to sublicense more than </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">5,500</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> patents issued and pending worldwide.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company manufactures and sells its proprietary OLED materials to customers for evaluation and use in commercial OLED products. The Company also enters into agreements with manufacturers of OLED display and lighting products under which it grants them licenses to practice under the Company’s patents and to use the Company's proprietary know-how. At the same time, the Company works with these and other companies that are evaluating the Company's OLED material, device design and manufacturing technologies for possible use in commercial OLED display and lighting products.</span></p>
CY2022Q1 oled Number Of Patents Issued And Pending Application
NumberOfPatentsIssuedAndPendingApplication
5500
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Management’s Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The estimates made are principally in the areas of revenue recognition including estimates of material unit sales and royalties, the useful life of acquired intangibles, lease liabilities, right-of-use assets, the use and recoverability of inventories, intangibles, investments and income taxes including realization of deferred tax assets, stock-based compensation and retirement benefit plan liabilities. Actual results could differ from those estimates.</span></p>
CY2022Q1 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
Recognized income tax positions are measured at the largest amount of which the likelihood of realization is greater than 50%.
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
357424000
CY2022Q1 oled Cash Equivalents Gross Unrealized Gain
CashEquivalentsGrossUnrealizedGain
0
CY2022Q1 oled Cash Equivalents Gross Unrealized Losses
CashEquivalentsGrossUnrealizedLosses
0
CY2022Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
357424000
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
311993000
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
311993000
CY2022Q1 oled Number Of Minority Investments
NumberOfMinorityInvestments
2
CY2022Q1 oled Minority Investment Carrying Value
MinorityInvestmentCarryingValue
8500000
CY2022Q1 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
0
CY2021Q4 us-gaap Other Than Temporary Impairment Credit Losses Recognized In Earnings Credit Losses On Debt Securities Held
OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
0
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
79834000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
75227000
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14974000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
16065000
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
48432000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
42868000
CY2022Q1 us-gaap Inventory Net
InventoryNet
143240000
CY2021Q4 us-gaap Inventory Net
InventoryNet
134160000
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
84000
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
667000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
229858000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
221293000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
97979000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
92461000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
131879000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
128832000
CY2022Q1 us-gaap Depreciation
Depreciation
5600000
CY2021Q1 us-gaap Depreciation
Depreciation
4300000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
223303000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
223303000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
178782000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
173635000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44521000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
49668000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
10600000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
9700000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9600000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9600000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
4800000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
200000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29645000
CY2022Q1 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
93293000
CY2021Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
103260000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
29645000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30614000
CY2022Q1 us-gaap Other Long Term Investments
OtherLongTermInvestments
3284000
CY2021Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
1836000
CY2022Q1 us-gaap Other Assets
OtherAssets
126222000
CY2021Q4 us-gaap Other Assets
OtherAssets
135710000
CY2022Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
Current lease agreements do not contain any residual value guarantees or material restrictive covenants. As of March 31, 2022, the Company did not have any finance leases and no additional operating leases that have not yet commenced.
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1098000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
615000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4720000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30614000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y3M18D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.028
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3054000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4009000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3957000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3999000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4012000
CY2022Q1 oled Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
14115000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
33146000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3501000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
29645000
CY2022Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
12997000
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
27686000
CY2022Q1 oled Accrued Ppg Agreements
AccruedPpgAgreements
6705000
CY2021Q4 oled Accrued Ppg Agreements
AccruedPpgAgreements
8853000
CY2022Q1 oled Accrued Research And Development Agreement Fees
AccruedResearchAndDevelopmentAgreementFees
1746000
CY2021Q4 oled Accrued Research And Development Agreement Fees
AccruedResearchAndDevelopmentAgreementFees
1469000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1432000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1000000
CY2022Q1 oled Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
645000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49099830
CY2021Q4 oled Accrued Consulting Fees Current
AccruedConsultingFeesCurrent
1314000
CY2022Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
154000
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
691000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3281000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4461000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26960000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45474000
CY2022Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
51060000
CY2021Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
47791000
CY2022Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
26312000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
27263000
CY2022Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
1089000
CY2021Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
1023000
CY2022Q1 us-gaap Other Liabilities
OtherLiabilities
78461000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
76077000
CY2022Q1 oled Long Term Purchase Commitment Percent Of Services Payable In Cash Or Shares
LongTermPurchaseCommitmentPercentOfServicesPayableInCashOrShares
0.50
CY2022Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
0
CY2021Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
0
CY2022Q1 oled Research And Development Expense Credit
ResearchAndDevelopmentExpenseCredit
1500000
CY2021Q1 oled Research And Development Expense Credit
ResearchAndDevelopmentExpenseCredit
1500000
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
7.50
CY2022Q1 oled Number Of Board Members Elected By Class Shareholders
NumberOfBoardMembersElectedByClassShareholders
2
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47734182
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
14200000
CY2022Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-4169000
CY2022Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-509000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3660000
CY2021Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-164000
CY2021Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1174000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1010000
CY2022Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-509000
CY2021Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1200000
CY2022Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
42300000
CY2021Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
25700000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.201
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.189
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12500000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12100000
CY2018Q4 oled Withholding And Interest For Licensing And Royalty Payments
WithholdingAndInterestForLicensingAndRoyaltyPayments
13200000
CY2018Q4 oled Withholding And Interest For Licencing And Royalty Payments Period
WithholdingAndInterestForLicencingAndRoyaltyPaymentsPeriod
P3Y
CY2022Q1 us-gaap Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
13200000
CY2022Q1 oled State And Foreign Income Tax Returns Subject To Examination Period Maximum
StateAndForeignIncomeTaxReturnsSubjectToExaminationPeriodMaximum
P4Y
CY2022Q1 us-gaap Revenues
Revenues
150470000
CY2021Q1 us-gaap Revenues
Revenues
134000000
CY2022Q1 us-gaap Noncurrent Assets
NoncurrentAssets
131879000
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
128832000
CY2022Q1 oled Number Of Suppliers From Which Chemical Materials Were Purchased
NumberOfSuppliersFromWhichChemicalMaterialsWerePurchased
1
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104947000
CY2022Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
12774000
CY2022Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
111778000
CY2022Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
31735000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47369764
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47267921
CY2022Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
191
CY2021Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
165
CY2022Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
70326
CY2022Q1 oled Backlog Associated With Committed Purchase Orders From Customers
BacklogAssociatedWithCommittedPurchaseOrdersFromCustomers
23800000
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
8127000
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
157081000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
57594000
CY2022Q1 oled Increases Due To Cash Received
IncreasesDueToCashReceived
-45891000
CY2022Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
1865000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
4647000
CY2022Q1 oled Unbilled Receivables Increase Decrease Net
UnbilledReceivablesIncreaseDecreaseNet
4647000
CY2022Q1 oled Net Increase Decrease In Deferred Revenue
NetIncreaseDecreaseInDeferredRevenue
13568000
CY2022Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
12774000
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
143513000
CY2020Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
10429000
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
162301000
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
33439000
CY2021Q1 oled Increases Due To Cash Received
IncreasesDueToCashReceived
-53000000
CY2021Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
3738000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
20471000
CY2021Q1 oled Transferred To Receivables From Unbilled Receivables
TransferredToReceivablesFromUnbilledReceivables
-6000000
CY2021Q1 oled Unbilled Receivables Increase Decrease Net
UnbilledReceivablesIncreaseDecreaseNet
14471000
CY2021Q1 oled Net Increase Decrease In Deferred Revenue
NetIncreaseDecreaseInDeferredRevenue
-15823000
CY2021Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
24900000
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
178124000
CY2022Q1 oled Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Decrease In Estimate Of Transaction Price
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueDecreaseInEstimateOfTransactionPrice
-1900000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
49970000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
51687000
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
325000
CY2021Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
358000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49645000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51329000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
61618
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47440281
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47329704
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.05
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.09
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.05
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.08
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14298
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0

Files In Submission

Name View Source Status
0000950170-22-007797-index-headers.html Edgar Link pending
0000950170-22-007797-index.html Edgar Link pending
0000950170-22-007797.txt Edgar Link pending
0000950170-22-007797-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img33762576_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
oled-20220331.htm Edgar Link pending
oled-20220331.xsd Edgar Link pending
oled-20220331_cal.xml Edgar Link unprocessable
oled-20220331_def.xml Edgar Link unprocessable
oled-20220331_htm.xml Edgar Link completed
oled-20220331_lab.xml Edgar Link unprocessable
oled-20220331_pre.xml Edgar Link unprocessable
oled-ex31_1.htm Edgar Link pending
oled-ex31_2.htm Edgar Link pending
oled-ex32_1.htm Edgar Link pending
oled-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending